An interventional study of High-frequency repetitive transcranial magnetic stimulation and lumbar puncture in Spinal Muscular Atrophy (SMA), sponsored by Charitable Foundation Children with Spinal Muscular Atrophy. Recruiting at 1 site in Ukraine. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2025-06-18.
Sponsored by Charitable Foundation Children with Spinal Muscular Atrophy · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
There is a general physiological rule that any organ or system needs some minimal amount of activity to prevent its atrophy or degeneration. Although the relevance of that rule to exercises in neuromuscular patients and for SMA in particular is not definitely proven, clinical observations seem to support this assumption. Also there are several experimental studies which provide additional support for utility of exercise for SMA.
However, making regular exercises may be very challenging with SMA not only due to physical limitations, but due to psychological either.
While being considered as safe and well tolerated intervention, TMS is able to mimic effects of real physical exercises, at least at the level of low motoneuron, it also provides several advantages. For example, possibility to exercise non-collaborative infants, minimization of psychological motivation impact in adults and/or ability to involve very weak muscle groups.
282 studies on the registry are indexed under Muscular Atrophy, Spinal; 71 are open to participants now.
This study's planned enrollment of 20 is below the median of 29 across 156 interventional studies indexed under Muscular Atrophy, Spinal.
Browse Muscular Atrophy, Spinal studies →Charitable Foundation Children with Spinal Muscular Atrophy is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Stimulation (HF-rTMS) of the primary motor cortex, M1 area of the limbs, at a frequency above 5 Hz and an intensity of 90-100% of the resting motor threshold (RMT), over 10 sessions, up to 2400 stimuli per session.
Device: High-frequency repetitive transcranial magnetic stimulation · Diagnostic Test: lumbar puncture
High-frequency repetitive transcranial magnetic stimulation targeting the primary motor cortex (M1) of the limbs, delivered at a frequency above 5 Hz and an intensity of 90-100% of the resting motor threshold, across 10 sessions with up to 2400 stimuli per session, is a standard intervention used in various neurological disorders. However, its effects have not been studied in patients with spinal muscular atrophy (SMA).
Also known as: HF-rTMS
Cerebrospinal fluid sampling to measure SMN protein and neurofilament concentrations before and after the TMS intervention.
Change from Baseline in the Motor Function Measure Scale
Motor Function Measure (MFM) scale measurement before and after TMS sessions
Time frame: The first assessment will be conducted before the initial TMS session, and the second will be performed one to two days after the final TMS session.
Change from Baseline of the Revised Upper Limb Module
Revised Upper Limb Module (RULM) scale measurement before and after TMS sessions
Time frame: The first assessment will be conducted before the initial TMS session, and the second will be performed one to two days after the final TMS session.
Change from Baseline of the Hammersmith Functional Motor Scale - Expanded
Hammersmith Functional Motor Scale - Expanded (HFMSE) measurement before and after TMS sessions
Time frame: The first assessment will be conducted before the initial TMS session, and the second will be performed one to two days after the final TMS session.
Change from Baseline in the 6-Minute Walk Test
6-Minute Walk Test (6MWT) measurement before and after TMS sessions
Time frame: The first assessment will be conducted before the initial TMS session, and the second will be performed one to two days after the final TMS session.
Plan to share: Yes — only IPD used in the results publication
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for Dec 2025, 7 months after the start.
Of 49 non-industry interventional studies with no phase under Muscular Atrophy, Spinal, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 7 months is below that.
Counting every sponsor, half of 58 studies reached it within 27 months; a quarter within 17 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charitable Foundation Children with Spinal Muscular Atrophy